Floatz logo

1-(2-Deoxy-?-D-erythro-pentofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione

5'-Nucleotidase Syndrome

National Center for Research Resources (NCRR)Small moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the 5'-Nucleotidase Syndrome cohort.

Asset / SponsorPhaseRating
URACIL RIBOSIDE
National Center for Research Resources (NCRR)
Phase 2B

Same molecule, other indications

1-(2-Deoxy-?-D-erythro-pentofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione is also rated in:

mitochondrial diseaseDormant
CCC
Indicative ·
53 / 100
View asset →
mitochondrial encephalomyopathyDormant
CCC
Indicative ·
53 / 100
View asset →
mitochondrial DNA depletion syndromeDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →